<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37686381</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Systemic Lupus Erythematosus and Antiphospholipid Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13581</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241713581</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown aetiology [...].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reshetnyak</LastName><ForeName>Tatiana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3552-2522</Identifier><AffiliationInfo><Affiliation>Department of Thromboinflammation, V.A. Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nurbaeva</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Thromboinflammation, V.A. Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="Y">Antiphospholipid Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065206" MajorTopicYN="Y">Extracellular Traps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest. All the authors participated in writing the manuscript. The final version has been approved by all the authors. The authors have not received any funding for this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37686381</ArticleId><ArticleId IdType="pmc">PMC10487763</ArticleId><ArticleId IdType="doi">10.3390/ijms241713581</ArticleId><ArticleId IdType="pii">ijms241713581</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nasonov E.L., Reshetnyak T.M., Solovyev S.K., Popkova T.V. Systemic lupus erythematosus and antiphospholipid syndrome: Past, present, future. Ter. Arkhiv. 2023;95:365&#x2013;374. doi: 10.26442/00403660.2023.05.202246.</Citation><ArticleIdList><ArticleId IdType="doi">10.26442/00403660.2023.05.202246</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshetnyak T.M., Cheldieva F.A., Nurbayeva K.S., Lila A.M., Nasonov E.L. Antiphospholipid syndrome: Diagnosis, development mechanism, therapy issues. Thromb. Hemost. Rheol. 2020;4:4&#x2013;21. doi: 10.25555/thr.2020.4.0940. (In Russian)</Citation><ArticleIdList><ArticleId IdType="doi">10.25555/thr.2020.4.0940</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardsson J., Sundelin B., Zickert A., Padyukov L., Svenungsson E., Gunnarsson I. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: An observational cross-sectional study with longitudinal follow-up. Arthritis Res. Ther. 2015;17:109. doi: 10.1186/s13075-015-0614-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0614-5</ArticleId><ArticleId IdType="pmc">PMC4443508</ArticleId><ArticleId IdType="pubmed">25927214</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero-Olvera P.R., Berebichez-Fridman R., Vel&#xe1;zquez-&#xc1;lvarez L., R&#xed;os-Morales J.R., Rodr&#xed;guez-Guiza M.A. Late diagnosis of systemic lupus erythematosus and antiphospholipid syndrome in an older woman with psychosis: A case report and review of the literature. Clin. Case Rep. 2017;5:1819&#x2013;1825. doi: 10.1002/ccr3.1185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.1185</ArticleId><ArticleId IdType="pmc">PMC5676278</ArticleId><ArticleId IdType="pubmed">29152278</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni P.L., Tsokos G.C. Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Front. Immunol. 2019;10:199. doi: 10.3389/fimmu.2019.00199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00199</ArticleId><ArticleId IdType="pmc">PMC6398508</ArticleId><ArticleId IdType="pubmed">30858846</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen L.L., Bisoendial R.J. B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy? J. Clin. Med. 2022;12:18. doi: 10.3390/jcm12010018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010018</ArticleId><ArticleId IdType="pmc">PMC9821657</ArticleId><ArticleId IdType="pubmed">36614819</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D.Y.H., Chan T.M. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis&#x2014;Role in Pathogenesis and Effect of Immunosuppressive Treatments. Int. J. Mol. Sci. 2019;20:6231. doi: 10.3390/ijms20246231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez D., Stojanovich L., Naranjo L., Stanisavljevic N., Bogdanovic G., Serrano M., Serrano A. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome. Front. Immunol. 2018;9:2644. doi: 10.3389/fimmu.2018.02644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02644</ArticleId><ArticleId IdType="pmc">PMC6256181</ArticleId><ArticleId IdType="pubmed">30524428</ArticleId></ArticleIdList></Reference><Reference><Citation>Naranjo L., Stojanovich L., Djokovic A., Andreoli L., Tincani A., Ma&#x15b;li&#x144;ska M., Sciascia S., Infantino M., Garcinu&#xf1;o S., Kostyra-Grabczak K., et al. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. Front. Immunol. 2022;13:957201. doi: 10.3389/fimmu.2022.957201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.957201</ArticleId><ArticleId IdType="pmc">PMC9511106</ArticleId><ArticleId IdType="pubmed">36172349</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonegio R.G., Lin J.D., Beaudette-Zlatanova B., York M.R., Menn-Josephy H., Yasuda K. Lupus-Associated Immune Complexes Activate Human Neutrophils in an Fc&#x3b3;RIIA-Dependent but TLR-Independent Response. J. Immunol. 2019;202:675&#x2013;683. doi: 10.4049/jimmunol.1800300.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800300</ArticleId><ArticleId IdType="pmc">PMC6344272</ArticleId><ArticleId IdType="pubmed">30610165</ArticleId></ArticleIdList></Reference><Reference><Citation>Menachem A., Chapman J., Katzav A. Significant Changes in the Levels of Secreted Cytokines in Brains of Experimental Antiphospholipid Syndrome Mice. Autoimmune Dis. 2012;2012:404815. doi: 10.1155/2012/404815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/404815</ArticleId><ArticleId IdType="pmc">PMC3290816</ArticleId><ArticleId IdType="pubmed">22454760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohl K., Tenbrock K. Inflammatory Cytokines in Systemic Lupus Erythematosus. J. Biomed. Biotechnol. 2011;2011:432595. doi: 10.1155/2011/432595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/432595</ArticleId><ArticleId IdType="pmc">PMC3196871</ArticleId><ArticleId IdType="pubmed">22028588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi S., Braunstein E.M., Brodsky R.A. Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications. J. Thromb. Haemost. 2021;19:607&#x2013;616. doi: 10.1111/jth.15082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15082</ArticleId><ArticleId IdType="pmc">PMC8080439</ArticleId><ArticleId IdType="pubmed">32881236</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein A., Alexander R.V., Zack D.J. A Review of Complement Activation in SLE. Curr. Rheumatol. Rep. 2021;23:16. doi: 10.1007/s11926-021-00984-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-021-00984-1</ArticleId><ArticleId IdType="pmc">PMC7875837</ArticleId><ArticleId IdType="pubmed">33569681</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenn R.C., Yalavarthi S., Gandhi A.A., Kazzaz N.M., N&#xfa;&#xf1;ez-&#xc1;lvarez C., Hern&#xe1;ndez-Ram&#xed;rez D., Cabral A.R., McCune W.J., Bockenstedt P.L., Knight J.S. Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome. Ann. Rheum. Dis. 2017;76:450&#x2013;457. doi: 10.1136/annrheumdis-2016-209442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-209442</ArticleId><ArticleId IdType="pmc">PMC5233467</ArticleId><ArticleId IdType="pubmed">27432357</ArticleId></ArticleIdList></Reference><Reference><Citation>Palli E., Kravvariti E., Tektonidou M.G. Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations. Front. Immunol. 2019;10:487. doi: 10.3389/fimmu.2019.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00487</ArticleId><ArticleId IdType="pmc">PMC6428719</ArticleId><ArticleId IdType="pubmed">30930907</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim T.M., Ong S.J., Mak A., Tay S.H. Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside. Int. J. Mol. Sci. 2022;23:2505. doi: 10.3390/ijms23052505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052505</ArticleId><ArticleId IdType="pmc">PMC8910773</ArticleId><ArticleId IdType="pubmed">35269647</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirestam L., Arve S., Linge P., Bengtsson A.A. Neutrophils&#x2014;Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Front. Immunol. 2019;10:2734. doi: 10.3389/fimmu.2019.02734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02734</ArticleId><ArticleId IdType="pmc">PMC6882868</ArticleId><ArticleId IdType="pubmed">31824510</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintero-Gonz&#xe1;lez D.C., Mu&#xf1;oz-Urbano M., V&#xe1;squez G. Mitochondria as a key player in systemic lupus erythematosus. Autoimmunity. 2022;55:497&#x2013;505. doi: 10.1080/08916934.2022.2112181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2022.2112181</ArticleId><ArticleId IdType="pubmed">35978536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Ishikawa T., Lai Y., Nallapothula D., Singh R.R. Diverse Roles of NETosis in the Pathogenesis of Lupus. Front. Immunol. 2022;13:895216. doi: 10.3389/fimmu.2022.895216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.895216</ArticleId><ArticleId IdType="pmc">PMC9170953</ArticleId><ArticleId IdType="pubmed">35686129</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalavarthi S., Gould T.J., Rao A.N., Mazza L.F., Morris A.E., N&#xfa;&#xf1;ez-&#xc1;lvarez C., Hern&#xe1;ndez-Ram&#xed;rez D., Bockenstedt P.L., Liaw P.C., Cabral A.R., et al. Release of Neutrophil Extracellular Traps by Neutrophils Stimulated with Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome. Arthritis Rheumatol. 2015;67:2990&#x2013;3003. doi: 10.1002/art.39247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39247</ArticleId><ArticleId IdType="pmc">PMC4626310</ArticleId><ArticleId IdType="pubmed">26097119</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorobjeva N.V., Chernyak B.V. NETosis: Molecular Mechanisms, Role in Physiology and Pathology. Biochemistry. 2020;85:1178&#x2013;1190. doi: 10.1134/S0006297920100065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297920100065</ArticleId><ArticleId IdType="pmc">PMC7590568</ArticleId><ArticleId IdType="pubmed">33202203</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz B.M., Acevedo O.A., Kalergis A.M., Bueno S.M. Role of Extracellular Trap Release during Bacterial and Viral Infection. Front. Microbiol. 2022;13:798853. doi: 10.3389/fmicb.2022.798853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.798853</ArticleId><ArticleId IdType="pmc">PMC8825568</ArticleId><ArticleId IdType="pubmed">35154050</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutua V., Gershwin L.J. A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics. Clin. Rev. Allergy Immunol. 2020;61:194&#x2013;211. doi: 10.1007/s12016-020-08804-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08804-7</ArticleId><ArticleId IdType="pmc">PMC7395212</ArticleId><ArticleId IdType="pubmed">32740860</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan M.J., Radic M. Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity. J. Immunol. 2012;189:2689&#x2013;2695. doi: 10.4049/jimmunol.1201719.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201719</ArticleId><ArticleId IdType="pmc">PMC3439169</ArticleId><ArticleId IdType="pubmed">22956760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulfig A., Leichert L.I. The effects of neutrophil-generated hypochlorous acid and other hypohalous acids on host and pathogens. Cell. Mol. Life Sci. 2020;78:385&#x2013;414. doi: 10.1007/s00018-020-03591-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03591-y</ArticleId><ArticleId IdType="pmc">PMC7873122</ArticleId><ArticleId IdType="pubmed">32661559</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Hong W., Wan M., Zheng L. Molecular mechanisms and therapeutic target of NETosis in diseases. Medcomm. 2022;3:e162. doi: 10.1002/mco2.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mco2.162</ArticleId><ArticleId IdType="pmc">PMC9390875</ArticleId><ArticleId IdType="pubmed">36000086</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva E., Yalavarthi S., Berthier C.C., Hodgin J.B., Khandpur R., Lin A.M., Rubin C.J., Zhao W., Olsen S.H., Klinker M., et al. Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus. J. Immunol. 2011;187:538&#x2013;552. doi: 10.4049/jimmunol.1100450.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100450</ArticleId><ArticleId IdType="pmc">PMC3119769</ArticleId><ArticleId IdType="pubmed">21613614</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler J., Martin M., Gullstrand B., Tyd&#xe9;n H., Lood C., Truedsson L., Bengtsson A.A., Blom A.M. Neutrophil Extracellular Traps That Are Not Degraded in Systemic Lupus Erythematosus Activate Complement Exacerbating the Disease. J. Immunol. 2012;188:3522&#x2013;3531. doi: 10.4049/jimmunol.1102404.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102404</ArticleId><ArticleId IdType="pubmed">22345666</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., Meller S., Chamilos G., Sebasigari R., Riccieri V., et al. Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA&#x2013;Peptide Complexes in Systemic Lupus Erythematosus. Sci. Transl. Med. 2011;3:73ra19. doi: 10.1126/scitranslmed.3001180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3001180</ArticleId><ArticleId IdType="pmc">PMC3399524</ArticleId><ArticleId IdType="pubmed">21389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kienh&#xf6;fer D., Hahn J., Stoof J., Csepregi J.Z., Reinwald C., Urbonaviciute V., Johnsson C., Mauer&#xf6;der C., Podolska M.J., Biermann M.H., et al. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight. 2017;2:e92920. doi: 10.1172/jci.insight.92920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.92920</ArticleId><ArticleId IdType="pmc">PMC5436535</ArticleId><ArticleId IdType="pubmed">28515366</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Romo G.S., Caielli S., Vega B., Connolly J., Allantaz F., Xu Z., Punaro M., Baisch J., Guiducci C., Coffman R.L., et al. Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus. Sci. Transl. Med. 2011;3:73ra20. doi: 10.1126/scitranslmed.3001201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3001201</ArticleId><ArticleId IdType="pmc">PMC3143837</ArticleId><ArticleId IdType="pubmed">21389264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-Y., Wang C.-T., Chen C.-Y., Kuo P.-Y., Wang C.-R., Shiau A.-L., Chang C.-H., Wu C.-L. Galectin-3 Mediates NETosis and Acts as an Autoantigen in Systemic Lupus Erythematosus-Associated Diffuse Alveolar Haemorrhage. Int. J. Mol. Sci. 2023;24:9493. doi: 10.3390/ijms24119493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24119493</ArticleId><ArticleId IdType="pmc">PMC10253376</ArticleId><ArticleId IdType="pubmed">37298447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraaij T., Kamerling S.W., de Rooij E.N., van Daele P.L., Bredewold O.W., Bakker J.A., Bajema I.M., Scherer H.U., Toes R.E., Huizinga T.J., et al. The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus. J. Autoimmun. 2018;91:45&#x2013;54. doi: 10.1016/j.jaut.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.03.003</ArticleId><ArticleId IdType="pubmed">29636274</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangou E., Chrysanthopoulou A., Mitsios A., Kambas K., Arelaki S., Angelidou I., Arampatzioglou A., Gakiopoulou H., Bertsias G.K., Verginis P., et al. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A) Ann. Rheum. Dis. 2019;78:238&#x2013;248. doi: 10.1136/annrheumdis-2018-213181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-213181</ArticleId><ArticleId IdType="pmc">PMC6352428</ArticleId><ArticleId IdType="pubmed">30563869</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Zhao W., Luo W., Subramanian V., O&#x2019;dell A.A., Yalavarthi S., Hodgin J.B., Eitzman D.T., Thompson P.R., Kaplan M.J. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Investig. 2013;123:2981&#x2013;2993. doi: 10.1172/JCI67390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI67390</ArticleId><ArticleId IdType="pmc">PMC3696545</ArticleId><ArticleId IdType="pubmed">23722903</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Subramanian V., O&#x2019;Dell A.A., Yalavarthi S., Zhao W., Smith C.K., Hodgin J.B., Thompson P.R., Kaplan M.J. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann. Rheum. Dis. 2015;74:2199&#x2013;2206. doi: 10.1136/annrheumdis-2014-205365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2014-205365</ArticleId><ArticleId IdType="pmc">PMC4320672</ArticleId><ArticleId IdType="pubmed">25104775</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Avondt K., Fritsch-Stork R., Derksen R.H.W.M., Meyaard L. Ligation of Signal Inhibitory Receptor on Leukocytes-1 Suppresses the Release of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus. PLoS ONE. 2013;8:e78459. doi: 10.1371/journal.pone.0078459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0078459</ArticleId><ArticleId IdType="pmc">PMC3799702</ArticleId><ArticleId IdType="pubmed">24205237</ArticleId></ArticleIdList></Reference><Reference><Citation>Gestermann N., Di Domizio J., Lande R., Demaria O., Frasca L., Feldmeyer L., Di Lucca J., Gilliet M. Netting Neutrophils Activate Autoreactive B Cells in Lupus. J. Immunol. 2018;200:3364&#x2013;3371. doi: 10.4049/jimmunol.1700778.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1700778</ArticleId><ArticleId IdType="pubmed">29632142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sule G., Abuaita B.H., Steffes P.A., Fernandes A.T., Estes S.K., Dobry C., Pandian D., Gudjonsson J.E., Kahlenberg J.M., O&#x2019;riordan M.X., et al. Endoplasmic reticulum stress sensor IRE1&#x3b1; propels neutrophil hyperactivity in lupus. J. Clin. Investig. 2021;131:e137866. doi: 10.1172/JCI137866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137866</ArticleId><ArticleId IdType="pmc">PMC8011900</ArticleId><ArticleId IdType="pubmed">33561013</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona-Rivera C., Zhao W., Yalavarthi S., Kaplan M.J. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann. Rheum. Dis. 2015;74:1417&#x2013;1424. doi: 10.1136/annrheumdis-2013-204837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204837</ArticleId><ArticleId IdType="pmc">PMC4143484</ArticleId><ArticleId IdType="pubmed">24570026</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden M., van den Hoogen L.L., Westerlaken G.H.A., Fritsch-Stork R.D.E., van Roon J.A.G., Radstake T.R.D.J., Meyaard L. Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome. Rheumatology. 2018;57:1228&#x2013;1234. doi: 10.1093/rheumatology/key067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key067</ArticleId><ArticleId IdType="pubmed">29608758</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D., Shida H., Tomaru U., Yoshida M., Nishio S., Atsumi T., Ishizu A. Enhanced Formation and Disordered Regulation of NETs in Myeloperoxidase-ANCA&#x2013;Associated Microscopic Polyangiitis. J. Am. Soc. Nephrol. 2014;25:990&#x2013;997. doi: 10.1681/ASN.2013060606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013060606</ArticleId><ArticleId IdType="pmc">PMC4005303</ArticleId><ArticleId IdType="pubmed">24385592</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dam L.S., Kraaij T., Kamerling S.W.A., Bakker J.A., Scherer U.H., Rabelink T.J., van Kooten C., Teng Y.K.O. Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody&#x2013;Associated Vasculitis Compared to Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:2047&#x2013;2058. doi: 10.1002/art.41047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41047</ArticleId><ArticleId IdType="pmc">PMC7384043</ArticleId><ArticleId IdType="pubmed">31313503</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Ghoneimy D.H., Hesham M., Hasan R., Tarif M., Gouda S. The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: Relation to disease activity and lupus nephritis. Clin. Rheumatol. 2019;38:2585&#x2013;2593. doi: 10.1007/s10067-019-04547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-019-04547-9</ArticleId><ArticleId IdType="pubmed">31030361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Bonanni A., Petretto A., Vaglio A., Pratesi F., Santucci L., Migliorini P., Bertelli R., Galetti M., Belletti S., et al. Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis. J. Rheumatol. 2020;47:377&#x2013;386. doi: 10.3899/jrheum.181232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.181232</ArticleId><ArticleId IdType="pmc">PMC6917988</ArticleId><ArticleId IdType="pubmed">31092713</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiam H.R., Wong S.L., Wagner D.D., Waterman C.M. Cellular Mechanisms of NETosis. Annu. Rev. Cell Dev. Biol. 2020;36:191&#x2013;218. doi: 10.1146/annurev-cellbio-020520-111016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-020520-111016</ArticleId><ArticleId IdType="pmc">PMC8499668</ArticleId><ArticleId IdType="pubmed">32663035</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Lightfoot Y.L., Seto N., Carmona-Rivera C., Moore E., Goel R., O&#x2019;neil L., Mistry P., Hoffmann V., Mondal S., et al. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7&#x2013;dependent lupus. JCI Insight. 2018;3:e124729. doi: 10.1172/jci.insight.124729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.124729</ArticleId><ArticleId IdType="pmc">PMC6328098</ArticleId><ArticleId IdType="pubmed">30518690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanata N., Shoda H., Hatano H., Nagafuchi Y., Komai T., Okamura T., Suzuki A., Gunarta I.K., Yoshioka K., Yamamoto K., et al. Peptidylarginine Deiminase 4 Promotes the Renal Infiltration of Neutrophils and Exacerbates the TLR7 Agonist-Induced Lupus Mice. Front. Immunol. 2020;11:1095. doi: 10.3389/fimmu.2020.01095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01095</ArticleId><ArticleId IdType="pmc">PMC7324481</ArticleId><ArticleId IdType="pubmed">32655553</ArticleId></ArticleIdList></Reference><Reference><Citation>Saisorn W., Saithong S., Phuengmaung P., Udompornpitak K., Bhunyakarnjanarat T., Visitchanakun P., Chareonsappakit A., Pisitkun P., Chiewchengchol D., Leelahavanichkul A. Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury. Front. Immunol. 2021;12:669162. doi: 10.3389/fimmu.2021.669162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.669162</ArticleId><ArticleId IdType="pmc">PMC8269073</ArticleId><ArticleId IdType="pubmed">34248948</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon R.A., Herter J.M., Rosetti F., Campbell A.M., Nishi H., Kashgarian M., Bastacky S.I., Marinov A., Nickerson K.M., Mayadas T.N., et al. Lupus and proliferative nephritis are PAD4 independent in murine models. JCI Insight. 2017;2:e92926. doi: 10.1172/jci.insight.92926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.92926</ArticleId><ArticleId IdType="pmc">PMC5436537</ArticleId><ArticleId IdType="pubmed">28515361</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell A.M., Kashgarian M., Shlomchik M.J. NADPH Oxidase Inhibits the Pathogenesis of Systemic Lupus Erythematosus. Sci. Transl. Med. 2012;4:157ra141. doi: 10.1126/scitranslmed.3004801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004801</ArticleId><ArticleId IdType="pmc">PMC3704198</ArticleId><ArticleId IdType="pubmed">23100627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hultqvist M., Olsson L.M., Gelderman K.A., Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol. 2009;30:201&#x2013;208. doi: 10.1016/j.it.2009.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.03.004</ArticleId><ArticleId IdType="pubmed">19356981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood C., Blanco L.P., Purmalek M.M., Carmona-Rivera C., De Ravin S.S., Smith C.K., Malech H.L., Ledbetter J.A., Elkon K.B., Kaplan M.J. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 2016;22:146&#x2013;153. doi: 10.1038/nm.4027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4027</ArticleId><ArticleId IdType="pmc">PMC4742415</ArticleId><ArticleId IdType="pubmed">26779811</ArticleId></ArticleIdList></Reference><Reference><Citation>A Fortner K., Blanco L.P., Buskiewicz I., Huang N., Gibson P.C., Cook D.L., Pedersen H.L., Yuen P.S.T., Murphy M.P., Perl A., et al. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice. Lupus Sci. Med. 2020;7:e000387. doi: 10.1136/lupus-2020-000387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000387</ArticleId><ArticleId IdType="pmc">PMC7199895</ArticleId><ArticleId IdType="pubmed">32343673</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Li T., Chen S., Gu Y., Ye S. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Arthritis Rheumatol. 2015;67:3190&#x2013;3200. doi: 10.1002/art.39296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39296</ArticleId><ArticleId IdType="pubmed">26245802</ArticleId></ArticleIdList></Reference><Reference><Citation>Demkow U. Molecular Mechanisms of Neutrophil Extracellular Trap (NETs) Degradation. Int. J. Mol. Sci. 2023;24:4896. doi: 10.3390/ijms24054896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054896</ArticleId><ArticleId IdType="pmc">PMC10002918</ArticleId><ArticleId IdType="pubmed">36902325</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mayouf S.M., Sunker A., Abdwani R., Al Abrawi S., Almurshedi F., Alhashmi N., Al Sonbul A., Sewairi W., Qari A., Abdallah E., et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 2011;43:1186&#x2013;1188. doi: 10.1038/ng.975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.975</ArticleId><ArticleId IdType="pubmed">22019780</ArticleId></ArticleIdList></Reference><Reference><Citation>Skiljevic D., Jeremic I., Nikolic M., Andrejevic S., Sefik-Bukilica M., Stojimirovic B., Bonaci-Nikolic B. Serum DNase I activity in systemic lupus erythematosus: Correlation with immunoserological markers, the disease activity and organ involvement. Clin. Chem. Lab. Med. 2013;51:1083&#x2013;1091. doi: 10.1515/cclm-2012-0521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2012-0521</ArticleId><ArticleId IdType="pubmed">23183758</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl J., Serpas L., Wang Y., Rashidfarrokhi A., Perez O.A., Sally B., Sisirak V., Soni C., Khodadadi-Jamayran A., Tsirigos A., et al. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J. Exp. Med. 2021;218:e20201138. doi: 10.1084/jem.20201138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201138</ArticleId><ArticleId IdType="pmc">PMC8020718</ArticleId><ArticleId IdType="pubmed">33783474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruchniak M.P., Ostafin M., Wachowska M., Jakubaszek M., Kwiatkowska B., Olesinska M., Zycinska K., Demkow U. Neutrophil extracellular traps generation and degradation in patients with granulomatosis with polyangiitis and systemic lupus erythematosus. Autoimmunity. 2019;52:126&#x2013;135. doi: 10.1080/08916934.2019.1631812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2019.1631812</ArticleId><ArticleId IdType="pubmed">31257985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny E.F., Raupach B., Abu Abed U., Brinkmann V., Zychlinsky A. Dnase1-deficient mice spontaneously develop a systemic lupus erythematosus-like disease. Eur. J. Immunol. 2019;49:590&#x2013;599. doi: 10.1002/eji.201847875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201847875</ArticleId><ArticleId IdType="pubmed">30758851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisirak V., Sally B., D&#x2019;agati V., Martinez-Ortiz W., &#xd6;z&#xe7;akar Z.B., David J., Rashidfarrokhi A., Yeste A., Panea C., Chida A.S., et al. Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity. Cell. 2016;166:88&#x2013;101. doi: 10.1016/j.cell.2016.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.034</ArticleId><ArticleId IdType="pmc">PMC5030815</ArticleId><ArticleId IdType="pubmed">27293190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakkim A., F&#xfc;rnrohr B.G., Amann K., Laube B., Abed U.A., Brinkmann V., Herrmann M., Voll R.E., Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. USA. 2010;107:9813&#x2013;9818. doi: 10.1073/pnas.0909927107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0909927107</ArticleId><ArticleId IdType="pmc">PMC2906830</ArticleId><ArticleId IdType="pubmed">20439745</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler J., Gullstrand B., J&#xf6;nsen A., Nilsson J., Martin M., Blom A.M., Bengtsson A.A. Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus. Arthritis Res. Ther. 2013;15:R84. doi: 10.1186/ar4264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4264</ArticleId><ArticleId IdType="pmc">PMC3978901</ArticleId><ArticleId IdType="pubmed">23945056</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler J., Ciacma K., Gullstrand B., Bengtsson A.A., Martin M., Blom A.M. A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources. Arthritis Res. Ther. 2015;17:205. doi: 10.1186/s13075-015-0726-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0726-y</ArticleId><ArticleId IdType="pmc">PMC4535789</ArticleId><ArticleId IdType="pubmed">26268365</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Lu X., Shu X., Tian X., Yang H., Yang W., Zhang Y., Wang G. Elevated Plasma cfDNA May be Associated with Active Lupus Nephritis and Partially Attributed to Abnormal Regulation of Neutrophil Extracellular Traps (NETs) in Patients with Systemic Lupus Erythematosus. Intern. Med. 2014;53:2763&#x2013;2771. doi: 10.2169/internalmedicine.53.2570.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.53.2570</ArticleId><ArticleId IdType="pubmed">25500436</ArticleId></ArticleIdList></Reference><Reference><Citation>Rother N., Pieterse E., Lubbers J., Hilbrands L., van der Vlag J. Acetylated Histones in Apoptotic Microparticles Drive the Formation of Neutrophil Extracellular Traps in Active Lupus Nephritis. Front. Immunol. 2017;8:1136. doi: 10.3389/fimmu.2017.01136.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01136</ArticleId><ArticleId IdType="pmc">PMC5604071</ArticleId><ArticleId IdType="pubmed">28959262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Petretto A., Santucci L., Vaglio A., Pratesi F., Migliorini P., Bertelli R., Lavarello C., Bartolucci M., Candiano G., et al. Neutrophil Extracellular Traps protein composition is specific for patients with Lupus nephritis and includes methyl-oxidized &#x3b1;enolase (methionine sulfoxide 93) Sci. Rep. 2019;9:7934. doi: 10.1038/s41598-019-44379-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44379-w</ArticleId><ArticleId IdType="pmc">PMC6538718</ArticleId><ArticleId IdType="pubmed">31138830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Sinico R.A., Moroni G., Pratesi F., Migliorini P., Galetti M., Murtas C., Tincani A., Madaio M., Radice A., et al. Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo: &#x3b1;-enolase and annexin AI. J. Am. Soc. Nephrol. 2014;25:2483&#x2013;2498. doi: 10.1681/ASN.2013090987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013090987</ArticleId><ArticleId IdType="pmc">PMC4214525</ArticleId><ArticleId IdType="pubmed">24790181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruschi M., Moroni G., Sinico R.A., Franceschini F., Fredi M., Vaglio A., Cavagna L., Petretto A., Pratesi F., Migliorini P., et al. Neutrophil Extracellular Traps in the Autoimmunity Context. Front. Med. 2021;8:614829. doi: 10.3389/fmed.2021.614829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.614829</ArticleId><ArticleId IdType="pmc">PMC8019736</ArticleId><ArticleId IdType="pubmed">33829021</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshetnyak T., Nurbaeva K., Ptashnik I., Kudriaeva A., Belogurov A., Jr., Lila A., Nasonov E. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Int. J. Mol. Sci. 2023;24:9210. doi: 10.3390/ijms24119210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24119210</ArticleId><ArticleId IdType="pmc">PMC10252548</ArticleId><ArticleId IdType="pubmed">37298160</ArticleId></ArticleIdList></Reference><Reference><Citation>Warnatsch A., Ioannou M., Wang Q., Papayannopoulos V. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316&#x2013;320. doi: 10.1126/science.aaa8064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa8064</ArticleId><ArticleId IdType="pmc">PMC4854322</ArticleId><ArticleId IdType="pubmed">26185250</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieterse E., Rother N., Garsen M., Hofstra J.M., Satchell S.C., Hoffmann M., Loeven M.A., Knaapen H.K., van der Heijden O.W., Berden J.H., et al. Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition. Arterioscler. Thromb. Vasc. Biol. 2017;37:1371&#x2013;1379. doi: 10.1161/ATVBAHA.117.309002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.309002</ArticleId><ArticleId IdType="pubmed">28495931</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H., Liu J., Li N., Zhang B., Nguyen V.D., Yao P., Feng J., Liu Q., Chen Y., Li G., et al. NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19. Clin. Immunol. 2023;254:109687. doi: 10.1016/j.clim.2023.109687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2023.109687</ArticleId><ArticleId IdType="pubmed">37419296</ArticleId></ArticleIdList></Reference><Reference><Citation>Donkel S.J., Wolters F.J., Ikram M.A., de Maat M.P.M. Circulating Myeloperoxidase (MPO)-DNA complexes as marker for Neutrophil Extracellular Traps (NETs) levels and the association with cardiovascular risk factors in the general population. PLoS ONE. 2021;16:e0253698. doi: 10.1371/journal.pone.0253698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253698</ArticleId><ArticleId IdType="pmc">PMC8357174</ArticleId><ArticleId IdType="pubmed">34379628</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S., Juo H.-H., Nielsen C.T., Tyden H., Bengtsson A.A., Lood C. Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus. J. Rheumatol. 2020;47:1652&#x2013;1660. doi: 10.3899/jrheum.190875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.190875</ArticleId><ArticleId IdType="pmc">PMC7520909</ArticleId><ArticleId IdType="pubmed">31839592</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanata N., Ota M., Tsuchida Y., Nagafuchi Y., Okamura T., Shoda H., Fujio K. Serum extracellular traps associate with the activation of myeloid cells in SLE patients with the low level of anti-DNA antibodies. Sci. Rep. 2022;12:18397. doi: 10.1038/s41598-022-23076-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23076-1</ArticleId><ArticleId IdType="pmc">PMC9626644</ArticleId><ArticleId IdType="pubmed">36319843</ArticleId></ArticleIdList></Reference><Reference><Citation>Duvvuri B., Lood C. Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases. Front. Immunol. 2019;10:502. doi: 10.3389/fimmu.2019.00502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00502</ArticleId><ArticleId IdType="pmc">PMC6433826</ArticleId><ArticleId IdType="pubmed">30941136</ArticleId></ArticleIdList></Reference><Reference><Citation>Atamaniuk J., Hsiao Y.-Y., Mustak M., Bernhard D., Erlacher L., Fodinger M., Tiran B., Stuhlmeier K.M. Analysing cell-free plasma DNA and SLE disease activity. Eur. J. Clin. Investig. 2011;41:579&#x2013;583. doi: 10.1111/j.1365-2362.2010.02435.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2010.02435.x</ArticleId><ArticleId IdType="pubmed">21128939</ArticleId></ArticleIdList></Reference><Reference><Citation>Tug S., Helmig S., Menke J., Zahn D., Kubiak T., Schwarting A., Simon P. Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients. Cell. Immunol. 2014;292:32&#x2013;39. doi: 10.1016/j.cellimm.2014.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2014.08.002</ArticleId><ArticleId IdType="pubmed">25243646</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendy O.M., Abdel-Motalib T., El Shafie M.A., Khalaf F.A., Kotb S.E., Khalil A., Ali S.R. Circulating cell free DNA as a predictor of systemic lupus erythematosus severity and monitoring of therapy. Egypt. J. Med. Hum. Genet. 2016;17:79&#x2013;85. doi: 10.1016/j.ejmhg.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmhg.2015.07.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelal I.T., Zakaria M.A., Sharaf D.M., Elakad G.M. Levels of plasma cell-free DNA and its correlation with disease activity in rheumatoid arthritis and systemic lupus erythematosus patients. Egypt. Rheumatol. 2016;38:295&#x2013;300. doi: 10.1016/j.ejr.2016.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejr.2016.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Song Y., Chang J., Zhou X., Qi Q., Tian X., Li M., Zeng X., Xu M., Zhang W., et al. High levels of circulating cell-free DNA are a biomarker of active SLE. Eur. J. Clin. Investig. 2018;48:e13015. doi: 10.1111/eci.13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13015</ArticleId><ArticleId IdType="pubmed">30079480</ArticleId></ArticleIdList></Reference><Reference><Citation>Furumoto Y., Smith C.K., Blanco L., Zhao W., Brooks S.R., Thacker S.G., Zarzour A., Scium&#xe8; G., Tsai W.L., Trier A.M., et al. Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction. Arthritis Rheumatol. 2017;69:148&#x2013;160. doi: 10.1002/art.39818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39818</ArticleId><ArticleId IdType="pmc">PMC5195893</ArticleId><ArticleId IdType="pubmed">27429362</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Homood I.A. Thrombosis in Systemic Lupus Erythematosus: A Review Article. ISRN Rheumatol. 2012;2012:428269. doi: 10.5402/2012/428269.</Citation><ArticleIdList><ArticleId IdType="doi">10.5402/2012/428269</ArticleId><ArticleId IdType="pmc">PMC3413961</ArticleId><ArticleId IdType="pubmed">22900201</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano E.M., Fernandez-Bello I., Sanz R.J., Marhuenda &#xc1;.R., Acu&#xf1;a P., Rom&#xe1;n M.T.A., Arias-Salgado E.G., Barcenilla S.G., Canales M.A., Jimenez-Yuste V., et al. Thrombin Generation Related to Netosis in Patients with Systemic Lupus Erythematosus. Blood. 2020;136((Suppl. S1)):10&#x2013;11. doi: 10.1182/blood-2020-141192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2020-141192</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu Z., Liu Z. Impact of Neutrophil Extracellular Traps on Thrombosis Formation: New Findings and Future Perspective. Front. Cell. Infect. Microbiol. 2022;12:910908. doi: 10.3389/fcimb.2022.910908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.910908</ArticleId><ArticleId IdType="pmc">PMC9195303</ArticleId><ArticleId IdType="pubmed">35711663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sira J., Eyre L. Physiology of haemostasis. Anaesth. Intensive Care Med. 2016;17:79&#x2013;82. doi: 10.1016/j.mpaic.2015.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mpaic.2015.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K., Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 2021;18:666&#x2013;682. doi: 10.1038/s41569-021-00552-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner D.D., Heger L.A. Thromboinflammation: From Atherosclerosis to COVID-19. Arterioscler. Thromb. Vasc. Biol. 2022;42:1103&#x2013;1112. doi: 10.1161/ATVBAHA.122.317162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.122.317162</ArticleId><ArticleId IdType="pmc">PMC9420806</ArticleId><ArticleId IdType="pubmed">35861953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs T.A., Brill A., Duerschmied D., Schatzberg D., Monestier M., Myers D.D., Jr., Wrobleski S.K., Wakefield T.W., Hartwig J.H., Wagner D.D. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA. 2010;107:15880&#x2013;15885. doi: 10.1073/pnas.1005743107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1005743107</ArticleId><ArticleId IdType="pmc">PMC2936604</ArticleId><ArticleId IdType="pubmed">20798043</ArticleId></ArticleIdList></Reference><Reference><Citation>Brill A., Fuchs T.A., Savchenko A.S., Thomas G.M., Martinod K., DE Meyer S.F., Bhandari A.A., Wagner D.D. Neutrophil extracellular traps promote deep vein thrombosis in mice. J. Thromb. Haemost. 2012;10:136&#x2013;144. doi: 10.1111/j.1538-7836.2011.04544.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04544.x</ArticleId><ArticleId IdType="pmc">PMC3319651</ArticleId><ArticleId IdType="pubmed">22044575</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinod K., Demers M., Fuchs T.A., Wong S.L., Brill A., Gallant M., Hu J., Wang Y., Wagner D.D. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl. Acad. Sci. USA. 2013;110:8674&#x2013;8679. doi: 10.1073/pnas.1301059110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301059110</ArticleId><ArticleId IdType="pmc">PMC3666755</ArticleId><ArticleId IdType="pubmed">23650392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazawa D., Tomaru U., Yamamoto C., Jodo S., Ishizu A. Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front. Immunol. 2012;3:333. doi: 10.3389/fimmu.2012.00333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00333</ArticleId><ArticleId IdType="pmc">PMC3495275</ArticleId><ArticleId IdType="pubmed">23162551</ArticleId></ArticleIdList></Reference><Reference><Citation>Savchenko A.S., Martinod K., Seidman M.A., Wong S.L., Borissoff J.I., Piazza G., Libby P., Goldhaber S.Z., Mitchell R.N., Wagner D.D. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J. Thromb. Haemost. 2014;12:860&#x2013;870. doi: 10.1111/jth.12571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12571</ArticleId><ArticleId IdType="pmc">PMC4055516</ArticleId><ArticleId IdType="pubmed">24674135</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer O.J., Li X., Teeling P., Mackaay C., Ploegmakers H.J., van der Loos C.M., Daemen M.J., de Winter R.J., van der Wal A.C. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb. Haemost. 2013;109:290&#x2013;297. doi: 10.1160/th12-06-0425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/th12-06-0425</ArticleId><ArticleId IdType="pubmed">23238559</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;ring Y., Soehnlein O., Weber C. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ. Res. 2017;120:736&#x2013;743. doi: 10.1161/CIRCRESAHA.116.309692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309692</ArticleId><ArticleId IdType="pubmed">28209798</ArticleId></ArticleIdList></Reference><Reference><Citation>Megens R.T.A., Vijayan S., Lievens D., D&#xf6;ring Y., van Zandvoort M.A.M.J., Grommes J., Weber C., Soehnlein O. Presence of luminal neutrophil extracellular traps in atherosclerosis. Thromb. Haemost. 2012;107:597&#x2013;598. doi: 10.1160/TH11-09-0650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH11-09-0650</ArticleId><ArticleId IdType="pubmed">22318427</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi F., Bellomo F., Singh S.S.A. Worsening Thrombotic Complication of Atherosclerotic Plaques Due to Neutrophils Extracellular Traps: A Systematic Review. Biomedicines. 2023;11:113. doi: 10.3390/biomedicines11010113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11010113</ArticleId><ArticleId IdType="pmc">PMC9855935</ArticleId><ArticleId IdType="pubmed">36672621</ArticleId></ArticleIdList></Reference><Reference><Citation>Laridan E., Denorme F., Desender L., Fran&#xe7;ois O., Andersson T., Deckmyn H., Vanhoorelbeke K., De Meyer S.F. Neutrophil extracellular traps in ischemic stroke thrombi. Ann. Neurol. 2017;82:223&#x2013;232. doi: 10.1002/ana.24993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24993</ArticleId><ArticleId IdType="pubmed">28696508</ArticleId></ArticleIdList></Reference><Reference><Citation>Noubouossie D.F., Whelihan M.F., Yu Y.-B., Sparkenbaugh E., Pawlinski R., Monroe D.M., Key N.S. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood. 2017;129:1021&#x2013;1029. doi: 10.1182/blood-2016-06-722298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-06-722298</ArticleId><ArticleId IdType="pmc">PMC5324715</ArticleId><ArticleId IdType="pubmed">27919911</ArticleId></ArticleIdList></Reference><Reference><Citation>Semeraro F., Ammollo C.T., Morrissey J.H., Dale G.L., Friese P., Esmon N.L., Esmon C.T. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: Involvement of platelet TLR2 and TLR4. Blood. 2011;118:1952&#x2013;1961. doi: 10.1182/blood-2011-03-343061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-03-343061</ArticleId><ArticleId IdType="pmc">PMC3158722</ArticleId><ArticleId IdType="pubmed">21673343</ArticleId></ArticleIdList></Reference><Reference><Citation>Elaskalani O., Abdol Razak N.B., Metharom P. Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones. Cell Commun. Signal. 2018;16:24. doi: 10.1186/s12964-018-0235-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-018-0235-0</ArticleId><ArticleId IdType="pmc">PMC5975482</ArticleId><ArticleId IdType="pubmed">29843771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., Coughlin S.R. Cathepsin G Activates Protease-activated Receptor-4 in Human Platelets. J. Biol. Chem. 2000;275:6819&#x2013;6823. doi: 10.1074/jbc.275.10.6819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.10.6819</ArticleId><ArticleId IdType="pubmed">10702240</ArticleId></ArticleIdList></Reference><Reference><Citation>Seif K., Alidzanovic L., Tischler B., Ibrahim N., Zagrapan B., Rauscher S., Salzmann M., Hell L., Mauracher L.-M., Budde U., et al. Neutrophil-Mediated Proteolysis of Thrombospondin-1 Promotes Platelet Adhesion and String Formation. Thromb. Haemost. 2018;118:2074&#x2013;2085. doi: 10.1055/s-0038-1675229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1675229</ArticleId><ArticleId IdType="pmc">PMC6298231</ArticleId><ArticleId IdType="pubmed">30419595</ArticleId></ArticleIdList></Reference><Reference><Citation>de Los Reyes-Garc&#xed;a A.M., Aroca A., Arroyo-Rodr&#xed;guez A.B., Garc&#xed;a-Barbera N., Vicente V., Gonz&#xe1;lez-Conejero R., Martinez C. Neutrophil extracellular trap components increase the expression of coagulation factors. Biomed. Rep. 2019;10:195&#x2013;201. doi: 10.3892/br.2019.1187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2019.1187</ArticleId><ArticleId IdType="pmc">PMC6403473</ArticleId><ArticleId IdType="pubmed">30906549</ArticleId></ArticleIdList></Reference><Reference><Citation>Oehmcke S., M&#xf6;rgelin M., Herwald H. Activation of the Human Contact System on Neutrophil Extracellular Traps. J. Innate Immun. 2009;1:225&#x2013;230. doi: 10.1159/000203700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000203700</ArticleId><ArticleId IdType="pmc">PMC6951039</ArticleId><ArticleId IdType="pubmed">20375580</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould T.J., Vu T.T., Swystun L.L., Dwivedi D.J., Mai S.H., Weitz J.I., Liaw P.C. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 2014;34:1977&#x2013;1984. doi: 10.1161/ATVBAHA.114.304114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.114.304114</ArticleId><ArticleId IdType="pubmed">25012129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Luo L., Braun O., Westman J., Madhi R., Herwald H., M&#xf6;rgelin M., Thorlacius H. Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice. Sci. Rep. 2018;8:4020. doi: 10.1038/s41598-018-22156-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22156-5</ArticleId><ArticleId IdType="pmc">PMC5838234</ArticleId><ArticleId IdType="pubmed">29507382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambas K., Chrysanthopoulou A., Vassilopoulos D., Apostolidou E., Skendros P., Girod A., Arelaki S., Froudarakis M., Nakopoulou L., Giatromanolaki A., et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann. Rheum. Dis. 2014;73:1854&#x2013;1863. doi: 10.1136/annrheumdis-2013-203430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203430</ArticleId><ArticleId IdType="pubmed">23873874</ArticleId></ArticleIdList></Reference><Reference><Citation>Stakos D.A., Kambas K., Konstantinidis T., Mitroulis I., Apostolidou E., Arelaki S., Tsironidou V., Giatromanolaki A., Skendros P., Konstantinides S., et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur. Heart J. 2015;36:1405&#x2013;1414. doi: 10.1093/eurheartj/ehv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv007</ArticleId><ArticleId IdType="pmc">PMC4458286</ArticleId><ArticleId IdType="pubmed">25660055</ArticleId></ArticleIdList></Reference><Reference><Citation>Folco E.J., Mawson T.L., Vromman A., Bernardes-Souza B., Franck G., Persson O., Nakamura M., Newton G., Luscinskas F.W., Libby P. Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1&#x3b1; and Cathepsin G. Arterioscler. Thromb. Vasc. Biol. 2018;38:1901&#x2013;1912. doi: 10.1161/ATVBAHA.118.311150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.118.311150</ArticleId><ArticleId IdType="pmc">PMC6202190</ArticleId><ArticleId IdType="pubmed">29976772</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen L.C., Bj&#xf8;rn S.E., Nordfang O. Effect of Leukocyte Proteinases on Tissue Factor Pathway Inhibitor. Thromb. Haemost. 1992;67:537&#x2013;541. doi: 10.1055/s-0038-1648489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1648489</ArticleId><ArticleId IdType="pubmed">1519213</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan R.E., Nelson R.M., Kilpatrick J., Newgren J.O., Esmon P.C., Fournel M.A. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction. J. Biol. Chem. 1989;264:10493&#x2013;10500. doi: 10.1016/S0021-9258(18)81648-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)81648-9</ArticleId><ArticleId IdType="pubmed">2732232</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammollo C.T., Semeraro F., Xu J., Esmon N.L., Esmon C.T. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb. Haemost. 2011;9:1795&#x2013;1803. doi: 10.1111/j.1538-7836.2011.04422.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04422.x</ArticleId><ArticleId IdType="pubmed">21711444</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng H., Yalavarthi S., Kanthi Y., Mazza L.F., Elfline M.A., Luke C.E., Pinsky D.J., Henke P.K., Knight J.S. In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis. Arthritis Rheumatol. 2017;69:655&#x2013;667. doi: 10.1002/art.39938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39938</ArticleId><ArticleId IdType="pmc">PMC5329054</ArticleId><ArticleId IdType="pubmed">27696751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha C., Zhang W., Gao F., Xu J., Jia R., Cai J., Liu Y. Anti-&#x3b2;2GPI/&#x3b2;2GPI induces neutrophil extracellular traps formation to promote thrombogenesis via the TLR4/MyD88/MAPKs axis activation. Neuropharmacology. 2018;138:140&#x2013;150. doi: 10.1016/j.neuropharm.2018.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.06.001</ArticleId><ArticleId IdType="pubmed">29883691</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi C., Capitani N., Benagiano M., Baldari C.T., Della Bella C., Macor P., Tedesco F., Borghi M.O., Maugeri N., D&#x2019;elios M.M., et al. Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome. Front. Immunol. 2023;13:1076167. doi: 10.3389/fimmu.2022.1076167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1076167</ArticleId><ArticleId IdType="pmc">PMC9868732</ArticleId><ArticleId IdType="pubmed">36700193</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y., Liu Y., Li F., Mu F., Zha C. Anti-&#x3b2;2GPI/&#x3b2;2GPI induces human neutrophils to generate NETs by relying on ROS. Cell Biochem. Funct. 2019;37:56&#x2013;61. doi: 10.1002/cbf.3363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3363</ArticleId><ArticleId IdType="pmc">PMC6590372</ArticleId><ArticleId IdType="pubmed">30701573</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Dong Y., Zhang Y., Shen D., Wang X., Ge R., Zhang M., Xia Y., Wang X. Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome. J. Cell. Mol. Med. 2020;24:6690&#x2013;6703. doi: 10.1111/jcmm.15321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15321</ArticleId><ArticleId IdType="pmc">PMC7299718</ArticleId><ArticleId IdType="pubmed">32369873</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Zuo Y., Zhang S., Makris U.E., Karp D.R., Li Z. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients. Chin. Med. J. 2022;135:658&#x2013;664. doi: 10.1097/CM9.0000000000001964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000001964</ArticleId><ArticleId IdType="pmc">PMC9276217</ArticleId><ArticleId IdType="pubmed">35143425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali R.A., Estes S.K., Gandhi A.A., Yalavarthi S., Hoy C.K., Shi H., Zuo Y., Erkan D., Knight J.S. Defibrotide Inhibits Antiphospholipid Antibody&#x2013;Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis. Arthritis Rheumatol. 2022;74:902&#x2013;907. doi: 10.1002/art.42017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42017</ArticleId><ArticleId IdType="pmc">PMC9050805</ArticleId><ArticleId IdType="pubmed">34725956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauracher L.-M., Krall M., Roi&#xdf; J., Hell L., Koder S., Hofbauer T.M., Gebhart J., Hayden H., Brostjan C., Ay C., et al. Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals. Rheumatology. 2020;60:1687&#x2013;1699. doi: 10.1093/rheumatology/keaa532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa532</ArticleId><ArticleId IdType="pmc">PMC8024003</ArticleId><ArticleId IdType="pubmed">33026085</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen L.L., Fritsch-Stork R.D.E., van Roon J.A.G., Radstake T.R.D.J. Low density granulocytes are increased in the antiphospholipid syndrome and are associated with anti-&#x3b2;2GPI antibodies: Comment on the article by Yalavarthi et al. Arthritis Rheumatol. 2016;68:1320&#x2013;1321. doi: 10.1002/art.39576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39576</ArticleId><ArticleId IdType="pubmed">26749538</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffler J., Stojanovich L., Shoenfeld Y., Bogdanovic G., Hesselstrand R., Blom A.M. Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome. Clin. Exp. Rheumatol. 2014;32:66&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">24295292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Yalavarthi S., Gockman K., Madison J.A., Gudjonsson J.E., Kahlenberg J.M., McCune W.J., Bockenstedt P.L., Karp D.R., Knight J.S. Anti&#x2013;Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome. Arthritis Rheumatol. 2020;72:2130&#x2013;2135. doi: 10.1002/art.41460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41460</ArticleId><ArticleId IdType="pmc">PMC7722115</ArticleId><ArticleId IdType="pubmed">32729667</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Navaz S., Tsodikov A., Kmetova K., Kluge L., Ambati A., Hoy C.K., Yalavarthi S., de Andrade D., Tektonidou M.G., et al. Anti&#x2013;Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody&#x2013;Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository. Arthritis Rheumatol. 2023;75:1407&#x2013;1414. doi: 10.1002/art.42489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42489</ArticleId><ArticleId IdType="pubmed">36862141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hell L., Lurger K., Mauracher L.-M., Grilz E., Reumiller C.M., Schmidt G.J., Ercan H., Koder S., Assinger A., Basilio J., et al. Altered platelet proteome in lupus anticoagulant (LA)-positive patients&#x2014;Protein disulfide isomerase and NETosis as new players in LA-related thrombosis. Exp. Mol. Med. 2020;52:66&#x2013;78. doi: 10.1038/s12276-019-0358-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0358-4</ArticleId><ArticleId IdType="pmc">PMC7000701</ArticleId><ArticleId IdType="pubmed">31956273</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazetto B.d.M., Hounkpe B.W., da Silva Saraiva S., Vieira-Damiani G., dos Santos A.P.R., Jacinto B.C., Vaz C.d.O., Mesquita G.T.V., Annichino-Bizzacchi J.M., De Paula E.V., et al. Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome. Thromb. Res. 2022;214:132&#x2013;137. doi: 10.1016/j.thromres.2022.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.05.001</ArticleId><ArticleId IdType="pubmed">35561448</ArticleId></ArticleIdList></Reference><Reference><Citation>Foret T., Dufrost V., du Mont L.S., Costa P., Lakomy C., Lagrange J., Lacolley P., Regnault V., Zuily S., Wahl D. A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: Impact on activated protein C resistance. Rheumatology. 2022;61:2993&#x2013;2998. doi: 10.1093/rheumatology/keab853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab853</ArticleId><ArticleId IdType="pubmed">34791113</ArticleId></ArticleIdList></Reference><Reference><Citation>Salet D.M., Bekkering S., Middeldorp S., van den Hoogen L.L. Targeting thromboinflammation in antiphospholipid syndrome. J. Thromb. Haemost. 2023;21:744&#x2013;757. doi: 10.1016/j.jtha.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2022.12.002</ArticleId><ArticleId IdType="pubmed">36696191</ArticleId></ArticleIdList></Reference><Reference><Citation>Sule G., Kelley W.J., Gockman K., Yalavarthi S., Vreede A.P., Banka A.L., Bockenstedt P.L., Eniola-Adefeso O., Knight J.S. Increased Adhesive Potential of Antiphospholipid Syndrome Neutrophils Mediated by &#x3b2;2 Integrin Mac-1. Arthritis Rheumatol. 2020;72:114&#x2013;124. doi: 10.1002/art.41057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41057</ArticleId><ArticleId IdType="pmc">PMC6935403</ArticleId><ArticleId IdType="pubmed">31353826</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Meng H., Coit P., Yalavarthi S., Sule G., Gandhi A.A., Grenn R.C., Mazza L.F., Ali R.A., Renauer P., et al. Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target. JCI Insight. 2017;2:e93897. doi: 10.1172/jci.insight.93897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.93897</ArticleId><ArticleId IdType="pmc">PMC5621930</ArticleId><ArticleId IdType="pubmed">28931754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak L., Sweet D.R., Thomas A., Lapping S.D., Kalikasingh K., Madera A., Vinayachandran V., Padmanabhan R., Vasudevan N.T., Myers J.T., et al. A targetable pathway in neutrophils mitigates both arterial and venous thrombosis. Sci. Transl. Med. 2022;14:eabj7465. doi: 10.1126/scitranslmed.abj7465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7465</ArticleId><ArticleId IdType="pmc">PMC10318551</ArticleId><ArticleId IdType="pubmed">36044595</ArticleId></ArticleIdList></Reference><Reference><Citation>Stachowicz A., Zabczyk M., Natorska J., Suski M., Olszanecki R., Korbut R., Wi&#x15b;niewski J.R., Undas A. Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism. Sci. Rep. 2018;8:17301. doi: 10.1038/s41598-018-35034-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35034-x</ArticleId><ArticleId IdType="pmc">PMC6251889</ArticleId><ArticleId IdType="pubmed">30470809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali R.A., Gandhi A.A., Meng H., Yalavarthi S., Vreede A.P., Estes S.K., Palmer O.R., Bockenstedt P.L., Pinsky D.J., Greve J.M., et al. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commum. 2019;10:1916. doi: 10.1038/s41467-019-09801-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09801-x</ArticleId><ArticleId IdType="pmc">PMC6478874</ArticleId><ArticleId IdType="pubmed">31015489</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredi A.A., Rovere-Querini P., D&#x2019;angelo A., Maugeri N. Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps. Pharmacol. Res. 2017;123:146&#x2013;156. doi: 10.1016/j.phrs.2016.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2016.08.008</ArticleId><ArticleId IdType="pubmed">28161237</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>